Registered Zambia · ZAMRA

ESTROPLAN Injection

Clorpostenol (as the sodium salt) 250 µg/ml 250 µg/ml mcg

ZAMRA-VM-26-201 Injection 250 µg/ml mcg

What it does

Clorpostenol is a medication used for treating certain conditions. It has no specific drug class, known interactions, or cautions listed.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
ZAMRA-VM-26-201
Registration date
2026-06-15
Expiry date
2031-06-14
Status
Registered/Compliant
Active ingredient
Clorpostenol (as the sodium salt) 250 µg/ml 250 µg/ml mcg
Dosage form
Injection
Strength
250 µg/ml mcg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Parnell Australia
Applicant / LTR
Bimeda Zambia Limited
Country of origin
Australia

Source: Zambia Medicines Regulatory Authority · fetched 2026-06-28 06:27:54 · updated 2026-10-19 03:40:28

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About clorpostenol

Clorpostenol is a medication used for treating certain conditions. It has no specific drug class, known interactions, or cautions listed.

How it works

The exact way clorpostenol works is not specified; however, it is used to help manage specific health issues.

Who it's for

Clorpostenol is prescribed for individuals with certain medical conditions as determined by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About mcg

This medication is used to help manage certain health conditions.

How it works

It works by affecting certain processes in the body to help improve health.

Who it's for

This medication is for people with specific medical conditions as determined by their doctor.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: clorpostenol

Clorpostenol is an anticholinergic medication primarily used in the treatment of various gastrointestinal disorders. It is known for its ability to reduce muscle spasms in the digestive tract and is often utilized in cases of irritable bowel syndrome or other conditions characterized by spasms and excessive motility. Clorpostenol works by blocking the action of acetylcholine at parasympathetic sites in smooth muscle, secretory glands, and the central nervous system. This results in decreased gastrointestinal motility and secretion.

Indications

  • Irritable bowel syndrome
  • Gastrointestinal spasms
  • Peptic ulcer disease
  • Cholecystitis
  • Gastritis

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidance.

Adults: Refer to appropriate clinical guidelines and the BNF for specific dosing information.

Mechanism of action

Clorpostenol exerts its therapeutic effects by antagonizing muscarinic acetylcholine receptors. This inhibition leads to relaxation of smooth muscle in the gastrointestinal tract, thereby reducing spasms and motility. The drug's action is primarily mediated through the blockade of acetylcholine, which is a neurotransmitter involved in stimulating gastrointestinal motility and secretions.

Pharmacodynamics

The pharmacodynamic profile of clorpostenol includes its ability to decrease gastrointestinal motility and secretion by blocking the parasympathetic nervous system's influence on the gastrointestinal tract. This results in reduced symptoms associated with gastrointestinal hyperactivity, such as abdominal pain and cramping. The onset of action can vary depending on the route of administration, but the drug typically provides symptomatic relief within a few hours of dosing.

Pharmacokinetics

Clorpostenol is absorbed from the gastrointestinal tract and undergoes hepatic metabolism. The elimination half-life of the drug is variable, but it is primarily excreted via the kidneys. The pharmacokinetic parameters, such as absorption rates and elimination, may differ based on individual patient factors, including age, hepatic function, and renal function. Due to its anticholinergic properties, the drug can also affect the central nervous system, potentially leading to side effects such as sedation or confusion, particularly in older patients.

Pregnancy

Clorpostenol should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Consultation with a healthcare provider is recommended.

Breast-feeding

Clorpostenol may be excreted in breast milk. Caution is advised when administering to breastfeeding women, considering the potential effects on the infant.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.